TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 102 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | +29.6% | 3,475 | +46.3% | 0.00% | +50.0% |
| Q2 2019 | $203,000 | -5.1% | 2,375 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $214,000 | +151.8% | 1,975 | +97.5% | 0.00% | +100.0% |
| Q4 2018 | $85,000 | -13.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $98,000 | -15.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | -55.2% | 1,000 | -56.5% | 0.00% | -50.0% |
| Q3 2017 | $259,000 | +44.7% | 2,300 | +43.8% | 0.00% | 0.0% |
| Q2 2017 | $179,000 | -4.3% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $187,000 | +11.3% | 1,600 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $168,000 | +281.8% | 1,600 | +300.0% | 0.00% | – |
| Q3 2016 | $44,000 | -81.1% | 400 | -75.0% | 0.00% | -100.0% |
| Q2 2016 | $233,000 | +28.0% | 1,600 | +35.9% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | – | 1,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |